UBS Maintains Neutral on Exponent, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 82.4%

Neg 82.4% Neu 0% Pos 0%

UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $85 to $75.

Comments

No comments yet. Be the first!